Advances in 3D and in vitro models have led to fundamental improvements in human disease modeling, drug development, toxicology testing, and more. As technology advances scientists are integrating human-relevant methods such as tissues-on-chips, 3D bioprinting, organoids, and other in vitro and in silico models into research to produce more reliable results. 

In light of the current coronavirus pandemic, the event has be moved online and will also feature discussions on the use of 3D biomimetic tissue models as predictive platforms to study infectious disease.

Our expert speakers include:

• Lena Smirnova, PhD, Johns Hopkins University, Center for Alternatives to Animal Testing
• Cleber Trujillo, PhD, University of California San Diego
• Cheryl A. Nickerson, PhD, Arizona State University

Everyone must register for the webinar, even if you preregistered for the in-person event. To sign up click here. 

Recordings from previous webinars on in silico and in vitro methods for toxicity testing are available here.